Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Vascular Endothelial Growth Factor (VGEF) Inhibitors Market: 36% Market Growth to Originate from North America | Technavio


NEW YORK, May 17, 2022 /PRNewswire/ -- Technavio categorizes the global vascular endothelial growth factor (VEGF) inhibitors market as a part of the pharmaceutical market within the overall healthcare industry. The vascular endothelial growth factor (VEGF) inhibitors market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Key Drivers, Trends, and Challenges

View market report outlook to learn more about factors influencing the market.

Vendor Insights

The report identifies the following as the dominant vendors in the market:

Product Insights and News

The vascular endothelial growth factor (VEGF) inhibitors market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. For instance, abbvie.com, one of the leading vendors under the operating segment, offers research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve established long-term strategic goals.

Learn more about the vendors in the market as you download your sample copy

North America's Contribution to the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market

The sales of approved VEGF inhibitors and the increasing prevalence of several cancer indications, including RCC, melanomas, and NSCLC, are expected to facilitate the vascular endothelial growth factor (VEGF) inhibitors market growth in North America over the forecast period. 36% of the market's growth will originate from North America during the forecast period as the US and Canada are the key markets for vascular endothelial growth factor (VEGF) inhibitors in North America. Market growth in this region will be slower than the growth of the market in the Asian and ROW regions.

Download report sample right here and know more about the market contribution in APAC

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.34%

Market growth 2022-2026

$ 8.95 billion

Market structure

Fragmented

YoY growth (%)

6.25

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key consumer countries

US, Canada, UK, Germany, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Amgen Inc., AstraZeneca Plc, AVEO Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb Co., Clovis Oncology Inc., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Viatris Inc., and Xbrane Biopharma AB

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Get your report sample copy to unlock scope and parent market analysis insights

Pandemic Impact

In 2020, the outbreak of COVID-19 adversely affected the US in North America. The outbreak led to radical changes and disturbances in various medical procedures. Moreover, the pandemic negatively impacted the growth of the regional VEGF inhibitors market in 2020 and the first half of 2021 and prompted vendors to develop new business strategies to deal with the impact. Vendors are implementing various strategies such as new product launches, M and A, and collaborations to enhance the growth of the market. 

Key Highlights

Related Reports:

Global Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2022-2026 Download your sample

Topical rugs Market by Product and Geography - Forecast and Analysis 2022-2026 Download your sample

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Application

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library and its client base consist of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:media@technavio.com
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 07:05
Precision BioSciences, Inc. (the "Company"), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced the closing of an underwritten offering of 35,971,224 shares of...

at 07:05
Primoris Services Corporation ("Primoris" or the "Company") announced today that it has entered into a definitive merger agreement to acquire PLH Group, Inc. ("PLH Group" or "PLH") in an all-cash transaction valued at $470 million. Primoris, one of...

at 07:05
Origin Materials, Inc. ("Origin," "Origin Materials," or the "Company") , the world's leading carbon negative materials company with a mission to enable the world's transition to sustainable materials, will join the small-cap Russell 2000® Index and...

at 07:05
The "Molecular Breeding Market Research Report by Marker (Simple Sequence Repeats (SSR) and Single Nucleotide Polymorphism (SNP)), Process, Type, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to...

at 07:05
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Nanorobotics - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities...

at 07:00
Gamesquare Esports Inc. ("GameSquare", or the "Company"), announces that GCN, Gamesquare's full-service media and marketing agency serving the sports and esports industry, has been awarded a significant contract by a new customer...



News published on 17 may 2022 at 01:15 and distributed by: